Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-01-05 @ 6:27 PM
Study NCT ID:
NCT01692951
Status:
COMPLETED
Last Update Posted:
2017-06-20
First Post:
2012-09-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer
Sponsor:
The Cleveland Clinic
Organization:
Study Overview
Official Title:
Serum Free Fatty Acid Metabolite Biomarkers of Lung Cancer
Status:
COMPLETED
Status Verified Date:
2017-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate the performance of serum free fatty acids as biomarkers for the identification of lung cancer.
Detailed Description:
We will compare the concentration of free fatty acids and their metabolites between patients with lung cancer and control pulmonary patients without known cancer. The diagnostic accuracy will be assessed for potential predictors.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: